ct041,darolutamide
bayer,carsgen therapeutics,orion corp
['darolutamide', 'ct041', 'dasl-hicap', 'prostate']
darolutamide augments standard therapy for localised very high-risk cancer of the prostate (dasl-hicap) (nct04136353) #prostatecancer clinical trial at #asco22 
The Prostate Cancer Clinical Trials Consortium (PCCTC) translates scientific discoveries to improved standards of care.